Publication Title |
Federal Register Volume
75, Issue 171
(September 3, 2010)
|
Category | Regulatory Information |
Collection | Federal Register |
SuDoc Class Number | AE 2.7: GS 4.107: AE 2.106: |
Publisher | Office of the Federal Register, National Archives and Records Administration |
Section | Rules and Regulations |
Action | Final rule. |
Dates | This rule is effective September 3, 2010. |
Contact | Cindy L. Burnsteel, Center for Veterinary Medicine (HFV-130), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 240-276-8341, e-mail: cindy.burnsteel@fda.hhs.gov. |
Summary | The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Intervet, Inc. The supplemental NADA adds Mycoplasma bovis to the bovine respiratory disease (BRD) pathogens for which use of an injectable solution containing florfenicol and flunixin meglumine is an approved treatment. |
Agency Names | DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration |
Page Number Range | 54018-54019 |
Federal Register Citation | 75
FR
54018 |
CFR Citation | 21
CFR
522 |
Docket Numbers | Docket No. FDA-2010-N-0002 |
FR Doc Number | 2010-22039 |
|
This is part of
Federal Register Volume
75, Issue 171
(September 3, 2010)
|
| View Entire Issue |
|